MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 10-K/A: Annual report (Amendment)
MIRA Pharmaceuticals | 424B5: Prospectus
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 10-K/A: Annual report (Amendment)
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 10-K: FY2024 Annual Report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 8-K: Current report
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Whalen Matthew Pratt
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shekhat Denil Nanji
MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
MIRA Pharmaceuticals | 8-K: Current report